United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights, & ProQuest (Firm). (1989). Competitive problems in the pharmaceutical drug industry: Hearing before the Subcommittee on Antitrust, Monopolas printed], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987. U.S. G.P.O..
Chicago Style (17th ed.) CitationUnited States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights, and ProQuest (Firm). Competitive Problems in the Pharmaceutical Drug Industry: Hearing Before the Subcommittee on Antitrust, Monopolas Printed], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, First Session, on the Generic Drug Industry and Its Concerns with Respect to Competition from the Brand Name Manufacturers, October 21, 1987. Washington: U.S. G.P.O., 1989.
MLA (9th ed.) CitationUnited States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights, and ProQuest (Firm). Competitive Problems in the Pharmaceutical Drug Industry: Hearing Before the Subcommittee on Antitrust, Monopolas Printed], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, First Session, on the Generic Drug Industry and Its Concerns with Respect to Competition from the Brand Name Manufacturers, October 21, 1987. U.S. G.P.O., 1989.